glp-1 receptor agonists and sglt2 inhibitors Illustration of potential synergistic effects of inhibitor with GLP1 Receptor Agonists vs SGLT2-I
Description
You can wear multiple PatchAid patches at the same time

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Phase 2 trials showed significant weight loss up to 20% at 52 weeks
What is the association between periconceptional GLP-1 receptor agonist exposure and risk of obstetric complications

TIIDM is primarily found in middle-aged and elderly individuals

Emanuel EJ, Dellgren JL, McCoy MS
